A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort

NCT01647685 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: Nanocort
DRUG: Methylprednisolone
DRUG: Placebo

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)